Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

Neukam, Karin; Caruz, Antonio; Rivero-Juárez, Antonio; More

AIDS . 27(17):2715-2724, November 13, 2013.

Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients

Macías, Juan; Camacho, Angela; Von Wichmann, Miguel A.; More

AIDS . 27(16):2541-2549, October 23, 2013.

The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype

Rivero-Juarez, Antonio; Lopez-Cortes, Luis F.; Camacho, Angela; More

AIDS . 27(12):1941-1947, July 31, 2013.

LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients

Rivero-Juarez, Antonio; Camacho, Angela; Caruz, Antonio; More

AIDS . 26(8):1009-1015, May 15, 2012.

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

Labarga, Pablo; Barreiro, Pablo; Mira, José A; More

AIDS . 25(8):1131-1133, May 15, 2011.